Kenneth S. Sharlin, MD – FDA Inspection, May 1, 2026

Record Details

This FDA Inspection record concerns Kenneth S. Sharlin, MD, with an inspection on May 1, 2026, issued by the Kansas City District Office, covering human drugs.

Company: Kenneth S. Sharlin, MD
Inspection Date: May 1, 2026
Product Type: Human Drugs
Office: Kansas City District Office
Person: Melissa S. Mcguinness (Investigator)

View Company Profile

ID · 21e6d47d-07ba-4327-89b6-db2f318cff7d

Inspection Facts

Inspection number: 1314968
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.62(b)Case history records- inadequate or inadequate

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Kenneth S. Sharlin, MD

FDA Inspection

Kenneth S. Sharlin, MDMay 1, 2026